--- title: Newsroom | Biotechnology (4) description: Biotechnology | (4) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) #### [Alithea Genomics launches MERCURIUS™ Total DRUG-seq: a next-generation full-length transcriptome profiling platform for high-throughput compound screening and target validation](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-mercurius-total-drug-seq-a-next-generation-full-length-transcriptome-profiling-platform-for-high-throughput-compound-screening-1750238414592) June 19, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-mercurius-total-drug-seq-a-next-generation-full-length-transcriptome-profiling-platform-for-high-throughput-compound-screening-1750238414592) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-mercurius-total-drug-seq-a-next-generation-full-length-transcriptome-profiling-platform-for-high-throughput-compound-screening-1750238414592#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 19, 2025, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery) April 24, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 24, 2025, 5:11:09 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Life Science](https://news.lifesciencenewswire.com/newsroom/tag/life-science) #### [ONTOFORCE’s DISQOVER chosen by The Michael J. Fox Foundation to enhance the integration and access of Parkinson’s disease research data](https://news.lifesciencenewswire.com/newsroom/ontoforces-disqover-chosen-by-the-michael-j.-fox-foundation-to-enhance-the-integration-and-access-of-parkinsons-disease-research-data) April 3, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ontoforces-disqover-chosen-by-the-michael-j.-fox-foundation-to-enhance-the-integration-and-access-of-parkinsons-disease-research-data) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ontoforces-disqover-chosen-by-the-michael-j.-fox-foundation-to-enhance-the-integration-and-access-of-parkinsons-disease-research-data#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 3, 2025, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Bioprocessing](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market](https://news.lifesciencenewswire.com/newsroom/abselion-raises-6.6-million-led-by-m-ventures-to-bring-disruptive-at-line-protein-analyser-amperia-to-market) December 4, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/abselion-raises-6.6-million-led-by-m-ventures-to-bring-disruptive-at-line-protein-analyser-amperia-to-market) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/abselion-raises-6.6-million-led-by-m-ventures-to-bring-disruptive-at-line-protein-analyser-amperia-to-market#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 4, 2024, 11:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-announces-first-patient-dosed-in-phase-i-trial-with-dsb2455-a-next-deneration-parp1-selective-inhibitor-for-the-treatment-of-solid-tumours) December 3, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-announces-first-patient-dosed-in-phase-i-trial-with-dsb2455-a-next-deneration-parp1-selective-inhibitor-for-the-treatment-of-solid-tumours) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-announces-first-patient-dosed-in-phase-i-trial-with-dsb2455-a-next-deneration-parp1-selective-inhibitor-for-the-treatment-of-solid-tumours#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 3, 2024, 10:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Research](https://news.lifesciencenewswire.com/newsroom/tag/research), [Life Science](https://news.lifesciencenewswire.com/newsroom/tag/life-science) #### [Takara Bio Europe unveils new large-scale NGS profiling system and chemistries](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-unveils-new-large-scale-ngs-profiling-system-and-chemistries) September 26, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-unveils-new-large-scale-ngs-profiling-system-and-chemistries) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-unveils-new-large-scale-ngs-profiling-system-and-chemistries#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 26, 2024, 9:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-granted-approval-by-european-medicines-agency-to-launch-next-generation-parp1-selective-inhibitor-trial) September 24, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-granted-approval-by-european-medicines-agency-to-launch-next-generation-parp1-selective-inhibitor-trial) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/duke-street-bio-granted-approval-by-european-medicines-agency-to-launch-next-generation-parp1-selective-inhibitor-trial#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 24, 2024, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Launch of a mutant RNA T7 polymerase with highly reduced double-stranded RNA formation](https://news.lifesciencenewswire.com/newsroom/launch-of-a-mutant-rna-t7-polymerase-with-highly-reduced-double-stranded-rna-formation) May 15, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/launch-of-a-mutant-rna-t7-polymerase-with-highly-reduced-double-stranded-rna-formation) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/launch-of-a-mutant-rna-t7-polymerase-with-highly-reduced-double-stranded-rna-formation#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 15, 2024, 11:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [Indica Labs receives first FDA clearance for HALO AP Dx digital pathology platform](https://news.lifesciencenewswire.com/newsroom/indica-labs-receives-first-fda-clearance-for-halo-ap-dx-digital-pathology-platform) May 14, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/indica-labs-receives-first-fda-clearance-for-halo-ap-dx-digital-pathology-platform) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/indica-labs-receives-first-fda-clearance-for-halo-ap-dx-digital-pathology-platform#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 14, 2024, 1:30:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology/page/3) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology/page/5) ##### Browse more news ## Recent releases #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) #### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) October 1, 2026 The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)